Yasser Ibrahim Orief
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasser Ibrahim Orief has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Samy El-Agwany
Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt; Shatby Gyne-oncology Specialized Center, Shatby Maternity University Hospital, Alexandria, Egypt
3 shared publications Emad Abd Elmoneem Darwish
3 shared publicationsKonstantinos Dafopoulos
Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
3 shared publicationsNikos Nikolettos
Laboratory of Reproductive Physiology, Faculty of Medicine, Demokritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece
3 shared publicationsSafaa Al-Hasani
University of Luebeck, Department of Obstetrics & Gynecology, Ratzeburger Allee 160, 23560, Luebeck, Germany
3 shared publicationsAskan Schultze-Mosgau
2 shared publications
Latest Publications
- Open Access
- 28 December 2023
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 309 (2) , 639-650
Expert consensus on the role of supplementation in obstetrics and gynecology using modified delphi method
Purpose: To reach a consensus among obstetrics and gynecology experts on the effects of micronutrient supplementation on fertility and pregnancy to aid clinicians in decision-making and create a unified approach to managing micronutrient deficiencies in women, by performing a modified Delphi study.Methods: A three-round modified Delphi process was conducted among a Delphi panel of 38 Egyptian experts to define recommendations regarding the role of supplementation on fertility and pregnancy in women of reproductive age. A literature review was performed and supporting evidence was graded to help guide the recommendations based on available evidence.Results: A total of 62 statements were developed for discussion and voting. Out of the 62 statements, 60 statements reached expert consensus. Statements were divided into two domains. The first domain discussed the role of supplementation in fertility: optimizing natural fertility, polycystic ovary syndrome (PCOS), in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), unexplained infertility, and endometriosis, whereas the second domain was concerned with the role of supplementation in pregnancy during the prenatal, antenatal, and postnatal periods.Conclusion: In this work, a modified Delphi methodology was implemented to reach a consensus on the use of micronutrient supplementation in women of reproductive age. These recommendations can help clinicians in their practice, guide future research, and identify gaps in the market for the pharmaceutical industry. This clinical guidance can be extrapolated to similar communities.
- 28 December 2023
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 309 (2) , 639-650
Open AccessExpert consensus on the role of supplementation in obstetrics and gynecology using modified delphi method
Purpose: To reach a consensus among obstetrics and gynecology experts on the effects of micronutrient supplementation on fertility and pregnancy to aid clinicians in decision-making and create a unified approach to managing micronutrient deficiencies in women, by performing a modified Delphi study.Methods: A three-round modified Delphi process was conducted among a Delphi panel of 38 Egyptian experts to define recommendations regarding the role of supplementation on fertility and pregnancy in women of reproductive age. A literature review was performed and supporting evidence was graded to help guide the recommendations based on available evidence.Results: A total of 62 statements were developed for discussion and voting. Out of the 62 statements, 60 statements reached expert consensus. Statements were divided into two domains. The first domain discussed the role of supplementation in fertility: optimizing natural fertility, polycystic ovary syndrome (PCOS), in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), unexplained infertility, and endometriosis, whereas the second domain was concerned with the role of supplementation in pregnancy during the prenatal, antenatal, and postnatal periods.Conclusion: In this work, a modified Delphi methodology was implemented to reach a consensus on the use of micronutrient supplementation in women of reproductive age. These recommendations can help clinicians in their practice, guide future research, and identify gaps in the market for the pharmaceutical industry. This clinical guidance can be extrapolated to similar communities.
- Open Access
- 1 March 2018
- Published by Taylor & Francis in Alexandria Journal of Medicine
- Vol. 54 (1) , 69-76
Group B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt
- 1 March 2018
- Published by Taylor & Francis in Alexandria Journal of Medicine
- Vol. 54 (1) , 69-76
Open AccessGroup B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt
- 1 February 2016
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 6 (1) , 14-20
Will intracytoplasmic morphologically selected sperm injection replace intracytoplasmic sperm injection in cases of severe oligo-astheno-teratozoospermia?
Objective The aim of the study was to compare between intracytoplasmic morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (ICSI) as regards laboratory and clinical outcomes in couples with severe oligo-astheno-teratozoospermia (OAT). Design This was a prospective, nonrandomized, controlled clinical trial. Setting The study was conducted in the Agial ICSI/IVF Center. Materials and methods A total of 1729 couples with severe OAT were enrolled: 1356 couples were submitted to routine ICSI (group I) and 373 couples were submitted to IMSI (group II) after they had been counselled about the possible role of the IMSI technique in increasing pregnancy rates. For IMSI, spermatozoa were selected at 6600× magnification using an inverted microscope. For conventional ICSI, spermatozoa were selected at 400× magnification. Main outcome measures Laboratory (fertilization rate, embryo quality, number of embryos transferred) and clinical outcomes (clinical pregnancy rate) were compared between the two groups. Both groups were comparable regarding the number of mature (MII) oocytes collected (P=0.36) and the total number of embryos transferred (P=0.202). No statistically significant difference was observed between the two groups regarding rates of fertilization (P=0.946), with a mean±SD of 63.47±25.15% in group I and 64.69±22.66% in group II. However, a statistically significant difference (PP=0.086). Major conclusion Our results suggest that IMSI provides a significant improvement in clinical pregnancy rates compared with ICSI in couples with severe OAT.
- 1 February 2016
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 6 (1) , 14-20
Will intracytoplasmic morphologically selected sperm injection replace intracytoplasmic sperm injection in cases of severe oligo-astheno-teratozoospermia?
Objective The aim of the study was to compare between intracytoplasmic morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (ICSI) as regards laboratory and clinical outcomes in couples with severe oligo-astheno-teratozoospermia (OAT). Design This was a prospective, nonrandomized, controlled clinical trial. Setting The study was conducted in the Agial ICSI/IVF Center. Materials and methods A total of 1729 couples with severe OAT were enrolled: 1356 couples were submitted to routine ICSI (group I) and 373 couples were submitted to IMSI (group II) after they had been counselled about the possible role of the IMSI technique in increasing pregnancy rates. For IMSI, spermatozoa were selected at 6600× magnification using an inverted microscope. For conventional ICSI, spermatozoa were selected at 400× magnification. Main outcome measures Laboratory (fertilization rate, embryo quality, number of embryos transferred) and clinical outcomes (clinical pregnancy rate) were compared between the two groups. Both groups were comparable regarding the number of mature (MII) oocytes collected (P=0.36) and the total number of embryos transferred (P=0.202). No statistically significant difference was observed between the two groups regarding rates of fertilization (P=0.946), with a mean±SD of 63.47±25.15% in group I and 64.69±22.66% in group II. However, a statistically significant difference (PP=0.086). Major conclusion Our results suggest that IMSI provides a significant improvement in clinical pregnancy rates compared with ICSI in couples with severe OAT.
- 1 January 2016
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- p. 1102-1107
Comparative study between intracytoplasmic morphologically selected sperm injection versus intracytoplasmic sperm injection in patients with severe male factor infertility and repeated intra cytoplasmic sperm injection failure
- 1 January 2016
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- p. 1102-1107
Comparative study between intracytoplasmic morphologically selected sperm injection versus intracytoplasmic sperm injection in patients with severe male factor infertility and repeated intra cytoplasmic sperm injection failure
- Open Access
- 1 January 2016
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- p. 1134-1139
Fixed gonadotropin-releasing hormone antagonist protocol versus gonadotropin-releasing hormone agonist long protocol in patients with polycystic ovary syndrome treated for intracytoplasmic sperm injection cycles
- 1 January 2016
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- p. 1134-1139
Open AccessFixed gonadotropin-releasing hormone antagonist protocol versus gonadotropin-releasing hormone agonist long protocol in patients with polycystic ovary syndrome treated for intracytoplasmic sperm injection cycles
- 1 November 2015
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 5 (4) , 180-184
Day-3 versus day-5 embryo transfer in intracytoplasmic sperm injection
Introduction In vitro fertilization (IVF) is fast becoming the gold standard for the treatment of infertility, with nearly a million IVF babies being born. The time of embryo transfer still rises a big question and is still a field of great debate as to whether the embryo should be transferred early at day 3 or one should wait until day 5 to give a good chance for embryo selection. This question has led us to design this prospective randomized clinical trial study aimed to determine whether embryo transfer on day 3 versus day 5 shows a significant difference in implantation, clinical pregnancy, live birth, miscarriage, and multiple pregnancy rates among women undergoing intracytoplasmic sperm injection. Patients and methods We included 240 infertile women retrieved from Alexandria University Hospital, who were randomly divided into two groups at the day of ovum pick up. Group I underwent day-3 embryo transfer, whereas group II underwent day-5 embryo transfer. Inclusion criteria were as follows: age less than 35 years, mild male factor, and normal uterine cavity. Women with endometriosis were excluded from the study. Results In the day-3 embryo transfer group 65 patients conceived, whereas in the day-5 embryo transfer group 66 patients conceived, which showed no significant difference between the two groups. There were 16 patients with multiple pregnancy in the day-3 embryo transfer group compared with 12 patients in the day-5 transfer group, which showed no significant difference between the two groups. There was only slight difference in live birth between the two groups; in the day-3 embryo transfer group there were 43 single live birth, whereas in the day-5 embryo transfer group there were 36 live births. Pearson’s χ2 test revealed no significant difference between the two groups as regards live birth (χ2=1.385, P=0.500). Conclusion There was no significant difference in the success rates and outcome of embryo transfer between the two groups.
- 1 November 2015
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 5 (4) , 180-184
Day-3 versus day-5 embryo transfer in intracytoplasmic sperm injection
Introduction In vitro fertilization (IVF) is fast becoming the gold standard for the treatment of infertility, with nearly a million IVF babies being born. The time of embryo transfer still rises a big question and is still a field of great debate as to whether the embryo should be transferred early at day 3 or one should wait until day 5 to give a good chance for embryo selection. This question has led us to design this prospective randomized clinical trial study aimed to determine whether embryo transfer on day 3 versus day 5 shows a significant difference in implantation, clinical pregnancy, live birth, miscarriage, and multiple pregnancy rates among women undergoing intracytoplasmic sperm injection. Patients and methods We included 240 infertile women retrieved from Alexandria University Hospital, who were randomly divided into two groups at the day of ovum pick up. Group I underwent day-3 embryo transfer, whereas group II underwent day-5 embryo transfer. Inclusion criteria were as follows: age less than 35 years, mild male factor, and normal uterine cavity. Women with endometriosis were excluded from the study. Results In the day-3 embryo transfer group 65 patients conceived, whereas in the day-5 embryo transfer group 66 patients conceived, which showed no significant difference between the two groups. There were 16 patients with multiple pregnancy in the day-3 embryo transfer group compared with 12 patients in the day-5 transfer group, which showed no significant difference between the two groups. There was only slight difference in live birth between the two groups; in the day-3 embryo transfer group there were 43 single live birth, whereas in the day-5 embryo transfer group there were 36 live births. Pearson’s χ2 test revealed no significant difference between the two groups as regards live birth (χ2=1.385, P=0.500). Conclusion There was no significant difference in the success rates and outcome of embryo transfer between the two groups.
- 1 November 2015
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 5 (4) , 157-160
Endometrial preparation for cryoembryo transfer
Objective The aim of the study was to compare artificial endometrial preparation using estrogen and progesterone with pretreatment with gonadotrophin-releasing hormone agonist along with estrogen or progesterone for cryoembryo transfer on the basis of clinical pregnancy rate. Design This was a randomized controlled trial. Setting The study was conducted at the Dar Al Khosouba Center. Sample A total of 140 couples underwent cryoembryo transfer as treatment for infertility between November 2013 and October 2014. Patients and methods Artificial endometrial preparation was performed for cryoembryo transfer. The main outcome measure was the clinical pregnancy rate. Results The couples were randomly subdivided equally into two groups: group A and group B. Group A underwent endometrial preparation with estrogen and progesterone, whereas group B underwent endometrial preparation by pretreatment with gonadotrophin-releasing hormone agonist along with estrogen or progesterone. The clinical pregnancy rate in group A was 50% and that in group B was 58.6%. There was no statistically significant difference in the clinical pregnancy rates between groups A and B. Conclusion Endometrial preparation for frozen–thawed embryo transfer based exclusively on steroid administration appears to be as effective as the protocol involving preliminary desensitization with a GnRha.
- 1 November 2015
- Published by Wolters Kluwer Health in Evidence Based Womenʼs Health Journal
- Vol. 5 (4) , 157-160
Endometrial preparation for cryoembryo transfer
Objective The aim of the study was to compare artificial endometrial preparation using estrogen and progesterone with pretreatment with gonadotrophin-releasing hormone agonist along with estrogen or progesterone for cryoembryo transfer on the basis of clinical pregnancy rate. Design This was a randomized controlled trial. Setting The study was conducted at the Dar Al Khosouba Center. Sample A total of 140 couples underwent cryoembryo transfer as treatment for infertility between November 2013 and October 2014. Patients and methods Artificial endometrial preparation was performed for cryoembryo transfer. The main outcome measure was the clinical pregnancy rate. Results The couples were randomly subdivided equally into two groups: group A and group B. Group A underwent endometrial preparation with estrogen and progesterone, whereas group B underwent endometrial preparation by pretreatment with gonadotrophin-releasing hormone agonist along with estrogen or progesterone. The clinical pregnancy rate in group A was 50% and that in group B was 58.6%. There was no statistically significant difference in the clinical pregnancy rates between groups A and B. Conclusion Endometrial preparation for frozen–thawed embryo transfer based exclusively on steroid administration appears to be as effective as the protocol involving preliminary desensitization with a GnRha.
- Open Access
- 1 June 2015
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 20 (2) , 102-107
Relationship between ultrasound parameters and intra cytoplasmic sperm injection outcome in polycystic ovarian syndrome treated by non agonist step up stimulation protocol
- 1 June 2015
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 20 (2) , 102-107
Open AccessRelationship between ultrasound parameters and intra cytoplasmic sperm injection outcome in polycystic ovarian syndrome treated by non agonist step up stimulation protocol
- Open Access
- 1 March 2015
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 20 (1) , 11-15
The effect of bed rest after intrauterine insemination on pregnancy outcome
- 1 March 2015
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 20 (1) , 11-15
Open AccessThe effect of bed rest after intrauterine insemination on pregnancy outcome